ELI LILLY & Co (LLY)
About ELI LILLY & Co
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $65.2B
- Net income
- $20.6B
- Total assets
- $112.5B
- Market cap
- $1.1T
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.1T
- Dividend yield
- 0.54%
- Shares outstanding
- 833.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 9, 1970
ELI LILLY & Co (LLY) Stock Price
- Profitable — net income of $20.6B in FY2025.
- Trading near its 52-week high.
- Pays a dividend yielding about 0.54% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ELI LILLY & Co.
Write a review
News about ELI LILLY & Co
News & sentiment via Polygon.io
ELI LILLY & Co: frequently asked questions
Is ELI LILLY & Co an American company?
Yes — ELI LILLY & Co is an American company headquartered in Indianapolis, Indiana. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is ELI LILLY & Co headquartered?
ELI LILLY & Co is headquartered in Indianapolis, Indiana, United States.
Is ELI LILLY & Co publicly traded?
Yes — ELI LILLY & Co is a publicly traded company. Its stock trades under the ticker symbol LLY on the NYSE.
What does ELI LILLY & Co do?
ELI LILLY & Co is an American Pharmaceuticals company in the Health & Beauty sector.
When was ELI LILLY & Co founded?
ELI LILLY & Co was founded in 1875.
